2
Announcements
Trials
Browse
Landscape
Status
Active not recruiting
1
Sponsor Class
OTHER
1
Study Type
Observational
1
Sponsor
Conditions
Breast Neoplasms
139
Neoplasms
118
Prostatic Neoplasms
64
Lung Neoplasms
48
Head and Neck Neoplasms
46
Colorectal Neoplasms
38
Ovarian Neoplasms
33
Uterine Cervical Neoplasms
29
Endometrial Neoplasms
23
Motor Activity
22
Neoplasm Metastasis
20
Multiple Myeloma
20
Pancreatic Neoplasms
19
Brain Neoplasms
19
Rectal Neoplasms
18
Lymphoma
17
Colonic Neoplasms
17
Pain
16
Gastrointestinal Neoplasms
16
Fatigue
16
Carcinoma, Non-Small-Cell Lung
16
Leukemia
15
Depression
15
Oropharyngeal Neoplasms
13
Melanoma
13
Anxiety Disorders
13
Urinary Bladder Neoplasms
12
Hematologic Neoplasms
12
Esophageal Neoplasms
12
Stomach Neoplasms
11
Interventions
Cyclophosphamide
14
fludarabine
9
fludarabine phosphate
8
Busulfan
5
Bendamustine Hydrochloride
5
Tacrolimus
4
Rituximab
4
Mycophenolic Acid
4
ibrutinib
3
Melphalan
3
Bortezomib
3
AP 1903 reagent
3
tetulomab tetraxetan lu-177
2
ponatinib
2
pembrolizumab
2
cobomarsen
2
Whole-Body Irradiation
2
Vorinostat
2
Vincristine
2
Prednisone
2
Peripheral Blood Stem Cell Transplantation
2
Patient Reported Outcome Measures
2
Mesna
2
Lutetium
2
Etoposide
2
Doxorubicin
2
Brentuximab Vedotin
2
Bone Marrow Transplantation
2
thymoglobulin
1
pimonidazole
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Immune System Diseases
×
Surveys and Questionnaires
×
Clear all
NCT04656873
2025-09-04
IOG
UNC Lineberger Comprehensive Cancer Center
Active not recruiting
32 enrolled